Company intelligence / Profile preview

Nscale

Ownership: Private
Development stage: Other

Overview

Nscale provides high-performance GPU cloud infrastructure optimized for large-scale AI model training and inference. Its solutions are tailored to accelerate protein structure prediction, drug discovery workflows, genomic data analysis, personalized medicine development, and multiomic research. The company's architecture is designed for scalability and performance with a focus on reducing time-to-insight for medical researchers. No clinical results apply since it is an enabling technology provider.

Modalities: AI-driven drug discoverygenomics analysis
Industry: Drug Discovery Services

Partnerships

ByteDanceNvidia

Beyond the preview

Go deeper on Nscale.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nscale.

Explore the full profile